Deutsche Bank’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,139
| Closed | -$398K | – | 5285 |
|
|
2019
Q3 | $398K | Sell |
21,139
-2,923
| -12% | -$33.4K | ﹤0.01% | 2792 |
|
|
2019
Q2 | $281K | Buy |
24,062
+4,586
| +24% | +$55.5K | ﹤0.01% | 3643 |
|
|
2019
Q1 | $265K | Sell |
19,476
-250,033
| -93% | -$3.24M | ﹤0.01% | 3837 |
|
|
2018
Q4 | $2.76M | Sell |
269,509
-73,492
| -21% | -$941K | ﹤0.01% | 2194 |
|
|
2018
Q3 | $5.71M | Sell |
343,001
-65,755
| -16% | -$1.19M | ﹤0.01% | 2077 |
|
|
2018
Q2 | $6.46M | Sell |
408,756
-112,552
| -22% | -$1.71M | ﹤0.01% | 2101 |
|
|
2018
Q1 | $6.62M | Buy |
521,308
+216,336
| +71% | +$3.13M | ﹤0.01% | 1979 |
|
|
2017
Q4 | $3.49M | Buy |
304,972
+61,611
| +25% | +$688K | ﹤0.01% | 2323 |
|
|
2017
Q3 | $2.98M | Buy |
243,361
+76,778
| +46% | +$801K | ﹤0.01% | 2261 |
|
|
2017
Q2 | $1.91M | Buy |
166,583
+44,813
| +37% | +$828K | ﹤0.01% | 2593 |
|
|
2017
Q1 | $2.53M | Sell |
121,770
-36,760
| -23% | -$814K | ﹤0.01% | 2102 |
|
|
2016
Q4 | $3.29M | Sell |
158,530
-25,295
| -14% | -$658K | ﹤0.01% | 1938 |
|
|
2016
Q3 | $6.02M | Buy |
183,825
+5,112
| +3% | +$156K | ﹤0.01% | 1617 |
|
|
2016
Q2 | $4.46M | Sell |
178,713
-130,452
| -42% | -$3.53M | ﹤0.01% | 1842 |
|
|
2016
Q1 | $7.57M | Buy |
309,165
+267,659
| +645% | +$6.2M | 0.01% | 1454 |
|
|
2015
Q4 | $1.37M | Sell |
41,506
-27,949
| -40% | -$945K | ﹤0.01% | 2682 |
|
|
2015
Q3 | $2.27M | Sell |
69,455
-19,498
| -22% | -$829K | ﹤0.01% | 2401 |
|
|
2015
Q2 | $4.71M | Buy |
88,953
+70,516
| +382% | +$2.56M | ﹤0.01% | 1841 |
|
|
2015
Q1 | $530K | Buy |
18,437
+18,403
| +54,126% | +$505K | ﹤0.01% | 3263 |
|
|
2014
Q4 | $0 | Sell |
34
-10,210
| -100% | -$183K | ﹤0.01% | 6424 |
|
|
2014
Q3 | $128K | Buy |
10,244
+2,164
| +27% | +$32.7K | ﹤0.01% | 4346 |
|
|
2014
Q2 | $161K | Buy |
+8,080
| New | +$114K | ﹤0.01% | 4270 |
|
Deutsche Bank's ALDR Position: Q4 2019 in Review
Deutsche Bank sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 21,139 shares — an estimated $398K sold.
Deutsche Bank first reported a position in ALDR in Q2 2014 and held it in 22 quarters. The position peaked at $7.57M in Q1 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Deutsche Bank reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Deutsche Bank sold 21,139 Alder Biopharmaceuticals shares in Q4 2019, an estimated $398K.
- Deutsche Bank first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 22 quarters.
- Deutsche Bank's Alder Biopharmaceuticals position peaked at $7.57M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.